Emerging Stocks Down Under 28 June 2022: Emyria (ASX:EMD)

Emyria
Emyria: If this company can't release a Schedule 3 product, no one will
If you thought cryptocurrencies were volatile, you haven’t heard of the cannabis sector. It has been through several booms and busts over the past few years, mostly booming when certain regulations are removed then gradually declining when it doesn’t turn out to be just like the easing of Prohibition. The latest regulation removed was the TGA’s declassification of certain CBD products, allowing them to be sold in pharmacies. We think Emyria (ASX: EMD) is on course to be one of the first companies to capitalise on this change, which is yet to be seen by investors. Click here to read the previous edition of Emerging Stocks Down Under published 21 June 2022 For in-depth research reports or to keep up-to-date on the latest Stocks Down Under news see our parent company, Pitt Street Research, or follow us on Facebook and Twitter.
Please register or upgrade your plan to access this content.

Save $$$
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$69
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$59
BILLED ANNUALLY
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar